CC
CLMT icon

Centiva Capital’s Calumet Specialty Products CLMT Stock Holding History

Centiva Capital’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,000
Closed -$254K – 1601
2025
Q1 		$254K Buy
+20,000
New +$314K 0.01% 1171

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Centiva Capital's CLMT Position: Q2 2025 in Review

Centiva Capital sold out of Calumet Specialty Products (CLMT) in Q2 2025, closing a stake of 20,000 shares — an estimated $254K sold.

Centiva Capital first reported a position in CLMT in Q1 2025 and held it in 1 quarter. The position peaked at $254K in Q1 2025. 134 funds tracked by Wall St. Rank hold CLMT as of Q2 2025.

  • Centiva Capital reported no remaining Calumet Specialty Products position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 20,000 Calumet Specialty Products shares in Q2 2025, an estimated $254K.
  • Centiva Capital first reported a position in Calumet Specialty Products in Q1 2025 and held it in 1 quarter.
  • Centiva Capital's Calumet Specialty Products position peaked at $254K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.